These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 19683863)
1. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Chen Y; Zhou Y; Qiu S; Wang K; Liu S; Peng XX; Li J; Tan EM; Zhang JY Cancer Lett; 2010 Mar; 289(1):32-9. PubMed ID: 19683863 [TBL] [Abstract][Full Text] [Related]
2. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma. Zhou JW; Li Y; Yue LX; Luo CL; Chen Y; Zhang JY Tumour Biol; 2016 Feb; 37(2):2547-53. PubMed ID: 26386724 [TBL] [Abstract][Full Text] [Related]
3. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685 [TBL] [Abstract][Full Text] [Related]
4. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715 [TBL] [Abstract][Full Text] [Related]
5. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma. Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685 [TBL] [Abstract][Full Text] [Related]
6. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system. Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436 [TBL] [Abstract][Full Text] [Related]
7. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma. Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer. Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877 [TBL] [Abstract][Full Text] [Related]
10. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer. Wang P; Qin J; Ye H; Li L; Wang X; Zhang J J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895 [TBL] [Abstract][Full Text] [Related]
11. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma. Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614 [TBL] [Abstract][Full Text] [Related]
12. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011 [TBL] [Abstract][Full Text] [Related]
13. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer. Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946 [TBL] [Abstract][Full Text] [Related]
15. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study. Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375 [TBL] [Abstract][Full Text] [Related]
16. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Himoto T; Kuriyama S; Zhang JY; Chan EK; Kimura Y; Masaki T; Uchida N; Nishioka M; Tan EM Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326 [TBL] [Abstract][Full Text] [Related]
17. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458 [TBL] [Abstract][Full Text] [Related]
18. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients. Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486 [TBL] [Abstract][Full Text] [Related]
19. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. Looi KS; Nakayasu ES; Diaz RA; Tan EM; Almeida IC; Zhang JY J Proteome Res; 2008 Sep; 7(9):4004-12. PubMed ID: 18672925 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma. Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]